LUTATHERA SOLUTION FOR INFUSION 370 MBQ/ML

Product Information

Registration Status: Active

LUTATHERA SOLUTION FOR INFUSION 370 MBQ/ML is approved to be sold in Singapore with effective from 2020-06-01. It is marketed by NOVARTIS (SINGAPORE) PTE LTD, with the registration number of SIN15947P.

This product contains Lutetium (177Lu) Oxodotreotide 370 Mbq/ml in the form of INJECTION, SOLUTION (RADIOPHARMACEUTICAL). It is approved for INTRAVENOUS use.

This product is manufactured by in ITALY, and in ITALY, and.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Lutetium (177Lu) Oxodotreotide


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank